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Among wealthy nations, most vaccine preventable 
diseases have become rarities due to childhood 
immunisation programs. Childhood immunisation 
programs demand an efficient primary health service, 
an effective cold chain and access to vaccines. 
Australia’s humanitarian program targets a cohort 
of people who come from countries in turmoil, often 
with very poor primary health infrastructure. In the 
2004–2005 financial year intake, at least 75% of the 
12 096 entrants who arrived in Australia under the 
offshore resettlement program came from countries 
with immunisation coverage rates below 50% in the 
1990s.1 A recent survey of African refugees in Melbourne 
(Victoria) found almost one half of those under 15 years 
of age were not immune to tetanus or measles.2 As a 
general rule, protection against vaccine preventable 
diseases in refugees appears to increase with age,3 
although among African refugees in Australia, this was 
not the case for tetanus.2 This is despite the policy in 
Afghanistan and many African countries of giving two 
doses of tetanus toxoid as part of antenatal care.4 
Refugees should have the same protection against 
vaccine preventable diseases as every other Australian 
resident. Refugees will often have poor health status and 
are likely to be more susceptible to vaccine preventable 
diseases. Most refugees need at least some component 
of catch up immunisation, and sometimes the entire 
primary course of immunisations, incorporated into their 
early health management. 
 Difficulties to be negotiated by general practitioners in 
crafting a catch up program for refugees are:
• knowing what immunisations to give
• planning catch up immunisation 
• getting the right vaccines at the right time, and 
• ensuring completion of immunisation courses.
Knowing what immunisations to give
Many refugees are unsure about their vaccination histories 
and do not have records (see Case study). Many refugees 
arriving from war torn regions of Africa have spent their 
early childhood in flight, and have not had access to 
routine childhood immunisations. It is generally unsafe to 
assume that residents of a refugee camp have had access 
to complete immunisation programs. While some camps 
have excellent immunisation programs for children under the 
age of 5 years, most adolescents and adults will only have 
received intermittent vaccination as part of disease eradication 
programs such as the Global Polio Eradication Initiative. 
 There are important differences between immunisation 
schedules in developing countries and those used in 
Australia. Tuberculosis vaccination (BCG) is part of most 
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schedules for neonates in developing countries, 
but is no longer part of the Australian schedule. In 
most African countries, monovalent immunisation 
against measles will be provided, while polyvalent 
measles/mumps/rubella (MMR) is provided 
in Australia. Haemophilis influenza B (Hib) 
vaccination is not part of the schedule of most 
countries of origin for refugees in the Australian 
humanitarian program. 
 In mid 2005, medical screening 72 hours 
before departure for Australia was introduced 
for refugees and some sponsored humanitarian 
entrants departing from eastern and western 
Africa, Egypt, Sudan and Thailand. This screening 
includes MMR vaccine for those aged less than 
30 years. This is recorded on an electronic health 
manifest, which is available to the local settlement 
service provider through the Department 
of Immigration and Citizenship (DIAC).5 It is 
important to note that not all refugees will have 
had this predeparture screening.
 If there is no written evidence of immunisation, 
should one test for serological evidence of 
immunity, or vaccinate at once? The small body of 
cost effectiveness research suggests that testing 
is not a cost effective strategy in situations where 
the patient may be lost to follow up.6,7 
 Refugees tend to be more mobile than other 
Australian residents, and are more likely to 
have periods of homelessness.8 The Australian 
Immunisation Handbook recommends that catch 
up immunisation be provided to all refugees 
who do not have documented evidence of 
immunisation,9 and so it would be prudent to start 
vaccination at the first consultation, if possible. 
 One of the challenges in providing catch up 
immunisation is calculating the correct age of 
a child. Many refugees have no birth record, 
children have been separated from the parents 
for periods of time, or life has been so disrupted 
that remembering a date of birth has not 
been possible. For some children, immigration 
authorities have estimated their age. Sometimes 
a detailed history, weight and height will help 
clarify a more realistic date of birth, so that the 
right schedule and vaccines are given. 
Planning catch up immunisation 
Catch up immunisation is notoriously tricky. 
Schedules change depending on the age of 
the person receiving catch up, with younger 
children generally needing a higher number 
of doses. Some immunisations, such as the 
hepatitis B vaccines Engerix-B and HBVax-II are 
interchangeable, while others, such as the Hib 
vaccines which are conjugated to meningococcal 
protein (LiquidPedaxHIB or ComVax) have a two 
dose schedule, while those conjugated to nontoxic 
diphtheria protein (HibTITER) or tetanus toxoid 
(Hiberix, ActHib) have a three dose schedule. 
Conjugated products containing Hib vaccines 
(Infanrix-Hexa, Pediacel or Poliacel) should not be 
used for children over the age of 5 years.
 Childhood vaccines with diphtheria toxoid 
contain 15 times the dose of diphtheria 
toxoid contained in adult diphtheria/tetanus 
vaccine. Inadvertent administration to adults 
or adolescents of vaccines containing doses 
intended for children (eg. diphtheria/tetanus/
pertussis [DTP] or the polyvalent childhood 
vaccines containing diphtheria toxoid) will 
result in marked swelling and tenderness at the 
injection site. Catch up vaccination for tetanus 
and diphtheria for children over the age of 8 years 
should use adult diphtheria/tetanus (Td), not the 
childhood vaccines containing the higher dose 
of diphtheria toxoid. Children should not receive 
more than six doses of DTP vaccine because of 
the increased risk of local reaction. If the person 
has tenderness and swelling in the arm, and the 
correct vaccine has been given for that person’s 
Case study
Habiba, 22 years of age, is from northern Afghanistan and arrived in Australia 
under the humanitarian program after spending 5 years living in Pakistan. This 
consultation, her first since arriving in Australia, is for a rash and fever at 10 
weeks of pregnancy. Rubella IgM antibodies are detected on serological testing. 
You also find that she is an asymptomatic carrier of hepatitis B and is positive 
for both hepatitis B surface antigen and hepatitis E antigen. She tells you that 
she believes she has been immunised on a few occasions in a refugee camp in 
Pakistan after leaving Afghanistan, but she is not sure what the vaccines were. 
She has no recollection and no record of having immunisations as a child.












Three doses, first two 1  
month apart, 2 months 
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1 month apart
Booster dose 6 months  
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1. Infanrix, Tripacel, Infanrix-IPV, Infanrix-Penta, Quadracel, Infanrix-Hep B. If Infanrix-Penta or Infanrix-Hep B used, allow 2 months between second and third doses  
2. MMR-II, Priorix
3. Engerix-B, HBVax II (paediatric formulation) or conjugated Infanrix-Hep B, Infanrix-Penta 
4. IPV or Infanrix-IPV, Infranrix-Penta or Quadracel. If Infanrix-Penta used, allow 2 months between second and third doses  
5. Neis-Vac C, Menjugate, Meningitec 
Better primary health care for refugees – catch up immunisationCLINICAL PRACTICE
442  Reprinted from Australian Family Physician Vol. 36, No. 6, June 2007
age, they should not be given further diphtheria/
tetanus immunisation.9 
 There are two types of pneumococcal vaccine 
available in Australia: the 7-valent conjugated 
pneumococcal vaccine Prevenar and the 23-valent 
polysaccharide vaccine Pneumovax. The routine 
childhood schedule includes three immunisations 
with Prevenar between 2–6 months of age. Catch 
up immunisation can be undertaken for children 
up to the age of 2 years and is not undertaken 
routinely after this. Refugees over 5 years of 
age who require immunisation against invasive 
pneumococcal disease (eg. those with sickle cell 
disease) should receive Pneumovax. 
 The MMR vaccine can inhibit the response 
to Mantoux tests, and so tuberculin testing for 
tuberculosis should be delayed for at least 4 weeks 
after MMR vaccination.8 Mantoux testing is often 
done in schools or a government or hospital chest 
clinic and needs to be properly coordinated with 
MMR immunisation. Although there is no evidence 
of the impact of varicella vaccine or live attenuated 
influenza vaccine on tuberculin tests, the Centres 
for Disease Control currently recommends that it 
would be prudent to also delay Mantoux testing for 
at least 1 month after these vaccinations.10 
 Figure 1, 2 shows funded immunisations for 
catch up for children aged 5–8 years and children 
and adults over the age of 8 years.
Getting the right vaccines
Catch up vaccination requires some flexibility 
in vaccine provision. In Australia, refugees face 
systematic gaps in immunisation provision. 
The Australian Immunisation Program is a joint 
state-federal initiative. Vaccines provided free 
from the national schedule are determined by 
states who tender for specific vaccines or vaccine 
combinations. Increasingly, states have begun 
to limit their free vaccines to those provided 
in childhood. 
 In 2005 all states in Australia began to 
structure their childhood immunisation schedule 
around polyvalent vaccines, in which up to six 
vaccines were provided in single conjugated form. 
Different states have elected to stock different 
polyvalent vaccines. Therefore, although the 
schedule is to a large extent harmonised across 
states, the vaccines provided are not. Polyvalent 
vaccines reduce the number of needles young 
children have, but for refugees over 8 years of 
age may paradoxically limit their capacity to 
access complete catch up immunisation. Some 
government funded programs for adolescents 
are conceived as one off ‘catch up’ programs. 
For example, government funded immunisation 
programs for meningococcal disease ceased for 
those aged 15–19 years in 2006 and for those 
aged 7–15 years in June 2007. 
 Because of the high prevalence of hepatitis 
B in many countries, one of the initial vaccines 
given should be hepatitis B, especially in the case 
of families where one member is a carrier (see 
Case study). All refugees should have a hepatitis 
B status assessment as part of their initial health 
examination, however giving hepatitis B vaccine 
to those already immune or to carriers does 
no harm. The combination vaccines containing 
childhood doses of diphtheria toxoid can only be 
used up to the age of 8 years.
 Adult diphtheria/tetanus is a central vaccine 
for catch up immunisation programs for adults 
and adolescents. Most states now provide adult 
diphtheria/tetanus/pertussis vaccine (Boostrix) 
rather than Td to immunisation providers as it 
also boosts protection against pertussis. Although 
the product information for Boostrix states it is 
not intended for primary immunisation, there is 
evidence supporting its role in a primary course in 
adults against pertussis, tetanus and diphtheria.11 
Doctors may still access Td through the 
emergency (doctor's bag) supplies section of the 
Pharmaceutical Benefits Scheme, which provides 
up to 15 doses of ADT-Booster per month. 
Although the product information for ADT-Booster 
states that the product is not intended for primary 
courses, it has similar constituents to Td, and 
therefore is equally suitable for primary vaccination. 
Accessing ADT-Booster through doctor's bag 
supplies can be cumbersome, and pharmacists 
have in the past few years experienced shortfalls 
in supply from the manufacturer. In all states, the 
new polyvalent vaccines include IPV. This means 
that states will need to provide monovalent IPV for 
catch up or primary immunisation for patients over 
8 years of age. 
 Failure to provide suitable vaccines for 
newly arrived refugees compounds the health 
inequities already suffered. Much refugee primary 
health care occurs in a policy vacuum. There 
is no formal statement by states that refugee 
adults and adolescents are entitled to full catch 
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Better primary health care for refugees – catch up immunisation CLINICAL PRACTICE
Reprinted from Australian Family Physician Vol. 36, No. 6, June 2007  443
up immunisation. In practice, many states do 
source and supply monovalent IPV and ADT on 
a case-by-case basis for catch up immunisation. 
Where there are refugee specific health services, 
these are generally provided with all catch up 
vaccines. General practitioners who provide care 
for refugees in their own practices may need to 
make direct requests their state public health unit 
to supply IPV and ADT when needed. 
Ensuring completion of immunisation 
courses
Resettlement is a demanding process for all 
refugees. Completion of an immunisation schedule 
may come lower on the priority list than finding 
employment and accommodation. It is important 
to provide a hand held record of the vaccinations 
given to refugees of all ages and, if the child is 
under 7 years of age, to document immunisations 
on the online Australian Childhood Immunisation 
Register (ACIR). A recall and reminder system and 
drop in appointment system for refugees to the 
clinic may support completion of immunisation 
schedules. School based catch up immunisation 
has been recommended in New South Wales for 
newly arrived refugee and migrant children.12 In 
the ACT, work based immunisation visits were 
introduced for businesses that employed a large 
number of newly arrived refugees. 
 Unfortunately,  the General  Pract ice 
Immunisation Incentives Scheme does not 
recognise catch up immunisation for children over 
7 years of age, so most providers of refugee 
primary health care will not be entitled to Service 
Incentive Payments (SIP) for completion of catch 
up schedules. The Enhanced Primary Care (EPC) 
refugee health assessment item number 714, 
introduced in 2006, provides some recognition of 
the extra time taken to ensure good assessment 
and early intervention for refugee health. 
Conclusion
Routine childhood vaccination is one of the 
major health advances of the past 60 years. 
Newly arrived refugees often have substandard 
protection against simple vaccine preventable 
diseases. Improving immunisation rates among 
this group of people should be a core general 
practice activity. Effective catch up immunisation 
programs in general practice require crafting a 
program that takes into consideration the age and 
immunisation history of the individual, a flexible 
delivery system, and support from public health 
units to provide the necessary vaccines. 
Resources
•  Information on immunisation schedules in different 
countries: www.who.int/immunization_monitoring/en/
globalsummary/scheduleselect.cfm  
•  Free translation of records written in languages other 
than English are funded through the Telephone and 
Interpreter Service and can be obtained at the Adult 
Migrant English Programs (a directory can be found on 
the Department of Immigration and Citizenship website 
or by telephoning the Telephone and Interpreter Service 
directly on 131450). Refugees on temporary protection 
visas are not eligible for this service 
•  An online calculator of catch up immunisation needs 
for children under 7 years of age is available at: www.
health.sa.gov.au/immunisationcalculator.
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